SCIENTIFIC PROGRAMME

Friday, 27 November 2020

Opening session
Chair: Ana-Maria Šimundić

8:45 – 9:00        Introductory note
                            Ana-Maria Šimundić (Croatia)

9:00 – 9:45        Opening lecture: Why do physicians order laboratory tests and what do they do with the results?
                            George Lundberg (USA)

9:45 – 10:30       Coffee break

Session: Defining the role of laboratory medicine
Chairs: George Lundberg, Tomris Ozben

10:30 – 11:00       The role of laboratory medicine in integrated clinical pathways
                                Giuseppe Lippi (Italy)

11:00 – 11:30       How to measure the contribution of laboratory medicine?
                                Mario Plebani (Italy)

11:30 – 12:00       How to effectively integrate knowledge and data into clinically actionable information?
                                Janne Cadamuro (Austria)

12:00 – 12:15       Practical examples (2 presenters, each 5-7 minutes)

12:15 – 13:30        Lunch

Session: How to manage the demand for laboratory testing?
Chairs: Ian Young, Pilar Fernandez Calle

13:30 – 13:50      Roundtable discussion: Who should decide what tests are performed?
<                            >The Laboratory perspective
<                            >Enrique Rodriguez Borja (Spain)

<                            >The Clinician’s perspective
<                            >Antoine Guillon (France)

13:50 – 14:10       Interactive discussion with the audience
                                Moderated by chairs

14:10 – 14:40       Existing tools and guidelines for demand management
                                Maria Salinas (Spain)

14:40 – 15:10       Lessons from diagnostic imaging
                                Boris Brkljačić (Croatia)

15:10 – 15:25       Practical examples (2 presenters, each 5-7 minutes)

15:25 – 16:00        Coffee break

Session: Challenges and benefits
Chairs: Janne Cadamuro, Maria Salinas

16:00 – 16:30        Barriers and challenges in implementing demand management interventions
                                 Ana-Maria Šimundić (Croatia)

16:30 – 17:00        Benefits to the laboratory
                                 Marielle Kaplan (Israel)

17:00 – 17:30        Benefits for the healthcare system (to the clinician, to the patient and economic benefits)
                                 Bernard Croal (UK)

17:30 – 17:45        Practical examples (2 presenters, each 5-7 minutes)

 

Saturday, 28 November 2020

Session: Views from other stakeholders – part I
Chairs: Mario Plebani, Dalius Vitkus

8:30 – 9:00           The patient perspective
                                Charlotte J. Haug (Norway)

9:00 – 9:30           The Clinician’s perspective
                                Anthony S Wierzbicki (UK)

9:30 – 10:00         A management perspective
                                To be defined

10:00 – 10:15       Practical examples (2 presenters, each 5-7 minutes)

10:15 – 11:00        Coffee break

Session: Views from other stakeholders – part II
Chairs: Giuseppe Lippi, Eric Kilpatrick

11:00 – 11:30       Policy makers and public health perspective
                                 Ian S.Young (UK)

11:30 – 12:10       View of the IVD industry: 10′ presentations each, followed by the moderated discussion.

This session will address following questions:

  • What actions are IVD companies undertaking to address demand management issues?
  • Why is doing less tests good for IVD company?
  • Can we do something together to address the problem of under- and over-utilization of tests?
    Roche (to be defined), Ortho (to be defined)

12:10 – 12:20       Interactive discussion with the audience
                                Moderated by chairs

12:20 – 12:50       Is the education and training of specialists in laboratory medicine fit for the future?
                                Gilbert Wieringa (UK)

12:50 – 13:30       Roundtable discussion (questions and voting)
                                Concluding remarks

Download the Scientific Programme